Raia Drogasil SA Stock Sao Paulo
Stocks
DROG3
BRDROGACNOR1
Drug Retailers
OTC Markets Traded|
End-of-day quote
Sao Paulo
|
||
| - BRL | - |
|
| 08-05 | Raia Drogasil S.A., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-04 | Raia Drogasil S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 31.75B 6.12B 5.37B 5.07B 4.62B 8.66B 587B 8.72B 60.7B 23.47B 299B 22.98B 22.49B 962B | P/E 2026 * |
21.6x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 39.84B 7.68B 6.74B 6.36B 5.8B 10.87B 736B 10.94B 76.15B 29.45B 376B 28.84B 28.21B 1,207B | EV / Sales 2026 * |
0.88x | EV / Sales 2027 * | 0.79x |
| Free-Float |
73.04% | Yield 2026 * |
2.05% | Yield 2027 * | 2.34% |
Last Transcript: Raia Drogasil SA
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2024-12-31 | |
| Director of Finance/CFO | 63 | 2013-04-28 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 50 | 2024-12-31 | |
| Director/Board Member | - | - | |
Gilberto Lerio
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.00% | -10.23% | +5.07% | -31.55% | 6.21B | |
| -0.49% | -2.15% | -22.27% | +25.24% | 1.21B | |
| +4.39% | +2.73% | +21.85% | +36.45% | 554M | |
| +0.11% | +0.07% | -12.18% | +27.12% | 65.88M | |
| Average | -1.00% | -3.15% | -1.88% | +14.32% | 2.01B | |
| Weighted average by Cap. | -5.95% | -7.53% | +1.96% | -17.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.4B 8.75B 7.68B 7.25B 6.61B 12.38B 839B 12.46B 86.79B 33.57B 428B 32.86B 32.15B 1,376B | 51.87B 10B 8.78B 8.28B 7.55B 14.15B 958B 14.24B 99.16B 38.35B 489B 37.55B 36.73B 1,572B |
| Net income | 1.51B 290M 255M 241M 219M 411M 27.82B 413M 2.88B 1.11B 14.2B 1.09B 1.07B 45.64B | 2.02B 389M 341M 322M 294M 550M 37.26B 554M 3.86B 1.49B 19.03B 1.46B 1.43B 61.14B |
| Net Debt | 8.09B 1.56B 1.37B 1.29B 1.18B 2.21B 149B 2.22B 15.46B 5.98B 76.25B 5.85B 5.73B 245B | 8.97B 1.73B 1.52B 1.43B 1.31B 2.45B 166B 2.46B 17.15B 6.63B 84.61B 6.49B 6.35B 272B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RADL3 Stock
- DROG3 Stock
Select your edition
All financial news and data tailored to specific country editions
